分或减去:转林和与未结合的铁结合能力 (UIBC)
Arne Åsberg1, Ann Elisabeth Åsberg2, Øyvind Skadberg1
1Department of Medical Biochemistry, Stavanger University Hospital, Stavanger, Norway.
Scandinavian journal of clinical and laboratory investigation
|February 20, 2026
概括
与转林和 (TSAT) 相比,无约束铁结合能力 (UIBC) 在诊断铁缺乏方面提供了更高的准确性. UIBC也较少受到炎症的影响,使其成为更可靠的指标.
科学领域:
- 临床化学 临床化学
- 血液学 血液学 血液学
- 诊断医学 诊断医学
背景情况:
- 血转激素和 (TSAT) 是铁缺乏症的传统标志物,但受炎症的影响.
- 血费里丁是铁缺乏症的首选指标,但TSAT仍然被广泛使用.
- 在炎症期间,未结合的铁结合能力 (UIBC) 的行为尚不清楚.
研究的目的:
- 为了评估UIBC和TSAT对铁缺乏症的诊断准确性.
- 评估炎症对UIBC,TSAT和费里水平的影响.
- 将UIBC和TSAT作为大量患者队列中缺铁指标进行比较.
主要方法:
- 从21,681名患者的数据进行横截面分析.
- 调查UIBC,TSAT,费里丁和C反应蛋白 (CRP) 之间的关系.
- 使用ROC曲线与费里丁值 (15,20,30μg/L) 作为非炎症子群 (CRP ≤1 mg/L) 的参考标准的诊断准确度的比较.
主要成果:
- 与TSAT和ferritin相比,UIBC显示CRP水平的变化明显较小.
- 与TSAT相比,UIBC对铁缺乏的诊断准确度更高 (AUC为0.894比0.850,使用费里<20μg/L).
- 约60μmol/L的UIBC值对应于20μg/L的费里水平,表明缺铁.
结论:
- 计算UIBC可以比TSAT更准确地评估铁缺乏症.
- UIBC是铁缺乏症的更强大的诊断标志物,特别是在炎症存在的情况下.
- UIBC代表了利用血铁和铁总结能力测量来诊断缺铁的卓越方法.
相关概念视频
The Early Endosome: Endocytosis of Transferrin
4.9K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.9K
Drug Distribution: Plasma Protein Binding
9.9K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
9.9K
Oxygen Transport in the Blood
7.3K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
7.3K
Physiological Pharmacokinetic Models: Assumption with Protein Binding
282
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
282
Hepatic Drug Clearance: Effect of Protein Binding
596
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
596
Blood Transfusion and Agglutination
15.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.1K


